Fusion event
HBV-chr9 integration
Detection method
PCR and Sanger sequencing
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGTTCACCAGCACCA| |TGCAACTTTTTCCCCTCTGCCTAATCATCTCATGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACATTGACCC
End
24396870/24396872 (Hg38)
Nearest miRNA
hsa-mir-101-2/Upstream/2884687; hsa-let-7a-1/Downstream/4466754;
Upstream sequence
TCTTTTGGACAGTAATTAAGCATAATAATTTATAGACTGATTCGGTAATTTTATTCTCTAGAATTTCTAATTATTCAACAAACAATATATGCACAGAACA
Downstream sequence
ttgcaggcagtctatcgtgggactttaccttgtgactgtgtgagtcaatcctccttaataaacttcctttcatatatacatatatcctattagttctgtc
Fujimoto, A., et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet,2012, 44(7): 760-764.